Phase 3 randomized double-blind study evaluating selinexor, an XPO1 inhibitor, plus ruxolitinib in jaki-naïve myelofibrosis: Study rationale and preliminary patient characteristics
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Phase 3 randomized double-blind study evaluating selinexor, an XPO1 inhibitor, plus ruxolitinib in jaki-naïve myelofibrosis: Study rationale and preliminary patient characteristics
Hsin‐An Hou, Antonín Hluší, Michael L. Loschi, Prithviraj Bose et al.
Journal
Blood
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment
article
Phase 3 randomized double-blind study evaluating selinexor, an XPO1 inhibitor, plus ruxolitinib in jaki-naïve myelofibrosis: Study rationale and preliminary patient characteristics
Hsin‐An Hou, Antonín Hluší, Michael L. Loschi, Prithviraj Bose, Pietro Taverna, Darko Miljkovic, Antonio Galleu, Jennifer O Sullivan, Valentín García‐Gutiérrez, Pankit J. Vachhani, Srinivas K. Tantravahi, Andrea Patriarca, Yi Chai, Haifa Kathrin Al‐Ali, Жанет Грудева-Попова, Sebastian Grosicki, Haris Ali, John O Mascarenhas, Emanuele Ammatuna, Raajit K. Rampal, Laura Urian, Von Potter, Sung Eun Lee
article en
Abstract
No abstract available for this paper.
Publication Tag
BloodVol. 146(Supplement 1)
Institutions
City Of Hope National Medical Center (US), University Medical Center Groningen (NL), Memorial Sloan Kettering Cancer Center (US), The University of Texas MD Anderson Cancer Center (US), Medical University of Silesia (PL), Guy's and St Thomas' NHS Foundation Trust (GB), Iuliu Hațieganu University of Medicine and Pharmacy (RO), Zurich Insurance Group (Switzerland) (CH), Medical University Plovdiv (BG), Huntsman Cancer Institute (US), Centre Hospitalier Universitaire de Nice (FR), University of Alabama at Birmingham (US), University Hospital Olomouc (CZ), Ospedale di Santo Spirito (IT), Thomas Foundation (AU), Menarini Group (Italy) (IT), City of Hope (US), Instituto Ramón y Cajal de Investigación Sanitaria (ES), National Taiwan University Hospital (TW), St Mary's Hospital (GB), Agricultural University Plovdiv (BG), St. Paul's Hospital (KR), University Hospital in Halle (DE), Karyopharm Therapeutics (United States) (US), The Catholic University of Korea Seoul St. Mary's Hospital (KR), Plovdiv University (BG), Palacký University Olomouc (CZ), University of Silesia in Katowice (PL), Icahn School of Medicine at Mount Sinai (US)
OpenAlex Percentile
Openalex Percentile: Top 43%
Topics
Myeloproliferative Neoplasms: Diagnosis and Treatment